Integrase-RNA interactions underscore the critical role of integrase in HIV-1 virion morphogenesis

被引:29
|
作者
Elliott, Jennifer L. [1 ]
Eschbach, Jenna E. [1 ]
Koneru, Pratibha C. [2 ]
Li, Wen [3 ,4 ]
Puray-Chavez, Maritza [1 ]
Townsend, Dana [1 ]
Lawson, Dana Q. [1 ]
Engelman, Alan N. [3 ,4 ]
Kvaratskhelia, Mamuka [2 ]
Kutluay, Sebla B. [1 ]
机构
[1] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA
[2] Univ Colorado, Sch Med, Div Infect Dis, Aurora, CO USA
[3] Dana Farber Canc Inst, Dept Canc Immunol & Virol, Boston, MA USA
[4] Harvard Med Sch, Dept Med, Boston, MA USA
来源
ELIFE | 2020年 / 9卷
基金
美国国家卫生研究院;
关键词
IMMUNODEFICIENCY-VIRUS TYPE-1; STRUCTURE-BASED MUTAGENESIS; TERMINAL DNA-BINDING; AMINO-ACID-RESIDUES; REVERSE TRANSCRIPTION; PROTEASOMAL DEGRADATION; ALLOSTERIC INHIBITORS; NUCLEOCAPSID PROTEIN; PARTICLE-PRODUCTION; GENETIC-ANALYSIS;
D O I
10.7554/eLife.54311
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
A large number of human immunodeficiency virus 1 (HIV-1) integrase (IN) alterations, referred to as class II substitutions, exhibit pleiotropic effects during virus replication. However, the underlying mechanism for the class II phenotype is not known. Here we demonstrate that all tested class II IN substitutions compromised IN-RNA binding in virions by one of the three distinct mechanisms: (i) markedly reducing IN levels thus precluding the formation of IN complexes with viral RNA; (ii) adversely affecting functional IN multimerization and consequently impairing IN binding to viral RNA; and (iii) directly compromising IN-RNA interactions without substantially affecting IN levels or functional IN multimerization. Inhibition of IN-RNA interactions resulted in the mislocalization of viral ribonucleoprotein complexes outside the capsid lattice, which led to premature degradation of the viral genome and IN in target cells. Collectively, our studies uncover causal mechanisms for the class II phenotype and highlight an essential role of IN-RNA interactions for accurate virion maturation.
引用
收藏
页数:28
相关论文
共 50 条
  • [41] Binding aspects of baicalein to HIV-1 integrase
    Ahn, HC
    Lee, SY
    Kim, JW
    Son, WS
    Shin, CG
    Lee, BJ
    [J]. MOLECULES AND CELLS, 2001, 12 (01) : 127 - 130
  • [42] Uneven Genetic Robustness of HIV-1 Integrase
    Rihn, Suzannah J.
    Hughes, Joseph
    Wilson, Sam J.
    Bieniasz, Paul D.
    [J]. JOURNAL OF VIROLOGY, 2015, 89 (01) : 552 - 567
  • [43] Styrylquinazoline derivatives as HIV-1 integrase inhibitors
    Lee, JY
    Park, JH
    Lee, SJ
    Park, H
    Lee, YS
    [J]. ARCHIV DER PHARMAZIE, 2002, 335 (06) : 277 - 282
  • [44] Discovery of novel HIV-1 integrase inhibitors
    Hong, HX
    Neamati, N
    Wang, SM
    Nicklaus, M
    Pommier, Y
    Milne, GWA
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 212 : 22 - MEDI
  • [45] Screening and identification of inhibitors on HIV-1 integrase
    Zou Yuan
    Zhan Jin-Biao
    [J]. PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2007, 34 (09) : 965 - 970
  • [46] HIV-1 Integrase Multimerization as a Therapeutic Target
    Feng, Lei
    Larue, Ross C.
    Slaughter, Alison
    Kessl, Jacques J.
    Kvaratskhelia, Mamuka
    [J]. FUTURE OF HIV-1 THERAPEUTICS: RESISTANCE IS FUTILE?, 2015, 389 : 93 - 119
  • [47] Strategies for identification of HIV-1 integrase inhibitors
    Ramcharan, Joseph
    Skalka, Anna Marie
    [J]. FUTURE VIROLOGY, 2006, 1 (06) : 717 - 731
  • [48] Design and discovery of HIV-1 integrase inhibitors
    Neamati, N
    Sunder, S
    Pommier, Y
    [J]. DRUG DISCOVERY TODAY, 1997, 2 (11) : 487 - 498
  • [49] HIV-1 integrase pharmacophore identification.
    Hong, HX
    Wang, SM
    Nicklause, MC
    Milne, GWA
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 213 : 38 - COMP
  • [50] HIV-1 Integrase Inhibitors That Are Active against Drug-Resistant Integrase Mutants
    Smith, Steven J.
    Zhao, Xue Zhi
    Passos, Dario Oliveira
    Lyumkis, Dmitry
    Burke, Terrence R., Jr.
    Hughes, Stephen H.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (09)